These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7532309)

  • 1. Methylenedioxyamphetamine: a selective effect on cortical content and turnover of 5-HT.
    Romano AG; Du W; Harvey JA
    Pharmacol Biochem Behav; 1994 Nov; 49(3):599-607. PubMed ID: 7532309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI; Williams JL; Green AR
    Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats.
    Yeh SY; Hsu FL
    Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Methylenedioxyamphetamine (MDA) self-administration and neurotoxicity.
    Markert LE; Roberts DC
    Pharmacol Biochem Behav; 1991 Jul; 39(3):569-74. PubMed ID: 1784586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
    Ballarín M; Carceller A; Guitart X
    Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G; Yeh SY; De Souza EB
    Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate.
    Gough B; Ali SF; Slikker W; Holson RR
    Pharmacol Biochem Behav; 1991 Jul; 39(3):619-23. PubMed ID: 1723797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives.
    Mamounas LA; Mullen CA; O'Hearn E; Molliver ME
    J Comp Neurol; 1991 Dec; 314(3):558-86. PubMed ID: 1814975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine.
    Harkin A; Shanahan E; Kelly JP; Connor TJ
    Eur J Neurosci; 2003 Aug; 18(4):1021-7. PubMed ID: 12925028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pineal melatonin and brain transmitter monoamines in CBA mice during chronic oral nicotine administration.
    Gäddnäs H; Pietilä K; Alila-Johansson A; Ahtee L
    Brain Res; 2002 Dec; 957(1):76-83. PubMed ID: 12443982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP; Nichols DE
    Pharmacol Biochem Behav; 1989 May; 33(1):105-8. PubMed ID: 2476831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
    Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M
    Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/C and C57Bl/6 mice: a comparative study].
    Narkevich VB; Kudrin VS; Klodt PM; Pokrovskiĭ AA; Kozlovskaia MM; Maĭskiĭ AI; Raevskiĭ KS
    Eksp Klin Farmakol; 2008; 71(5):8-12. PubMed ID: 19093364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations.
    Miller RT; Lau SS; Monks TJ
    Eur J Pharmacol; 1997 Apr; 323(2-3):173-80. PubMed ID: 9128836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.